Insulin Syringe

Low raw material and production costs

China has a well-established chemical industry system, and the supply of medical plastics, stainless steel, and other raw materials required for insulin syringe production is sufficient and relatively stable in price. At the same time, the automation production level of Chinese factories continues to improve, with abundant labor resources and relatively low labor costs, effectively controlling production costs and making domestic insulin syringes more competitive in price.

Centralized procurement promotes cost reduction

The implementation of domestic centralized procurement policies has prompted enterprises to further optimize production processes and reduce costs, which has also made the price advantage of domestic insulin syringes more obvious in the international market, meeting the demand of more patients worldwide for cost-effective medical devices.